As time goes on, clinical trials of vaccines against Govt-19 are being updated little by little, one of which is Moderna, as it turns out 90 percent effective against disease The American Institute of Biotechnology, announced in the newly released results, is slightly lower than the previous clinical trial.
The Phase 3 data comes from clinical trials It was attended by more than 30,000 people in the United States. The efficiency is slightly lower than the 94.1 percent recorded in a major clinical trial published New England Journal of Medicine In December.
Moderna did not say in its report whether the decline in performance was due to the emergence of new varieties, pEuro Biotech Company You are working on two revised versions of your vaccine, Noted for variations, with encouraging results in mice, but they have not yet been reviewed.
“New advance information about our variant-specific vaccine candidates gives us confidence in our ability to anticipate the emergence of new variants,” praised Stephen Boncel, president of Moderna.
As of April 12, Moderna said it had shipped 132 million doses of its Govt vaccine worldwide, including 117 million in the United States.
It is on track to deliver an additional 100 million doses to Americans by the end of May and another 100 million by the end of June.
The company’s clinical trial for adolescents aged 12 to 17 has approximately 3,000 participants in the United States, and its trial for children aged 6 months to 11 years continues to enroll 6,750 participants in the United States and China.